Skip to content

Clinical trials

Myocardial Infarction trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Country / region: Russia Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20062
20071
20083
20091
20101
20112
20136
20145
20153
20172
20184
20194
20205
20216
20222
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Recruiting10
Unknown status6
Terminated3
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tomsk National Research Medical Center of the Russian Academy of Sciences6
Meshalkin Research Institute of Pathology of Circulation4
Novartis Pharmaceuticals4
AstraZeneca3
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation3
AO GENERIUM2
Boehringer Ingelheim2
Janssen Research & Development, LLC2
Novartis2
Penza State University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction59
Stroke14
Acute Coronary Syndrome10
Cardiovascular Diseases9
ST Elevation Myocardial Infarction8
Coronary Artery Disease7
Angina, Unstable6
Heart Failure6
Myocardial Ischemia4
Diabetes Mellitus3

Trials

Showing 26 to 50 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.